Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids - PubMed (original) (raw)
Clinical Trial
. 2013 Apr;98(4):E708-12.
doi: 10.1210/jc.2012-3736. Epub 2013 Mar 1.
Affiliations
- PMID: 23457410
- PMCID: PMC3615197
- DOI: 10.1210/jc.2012-3736
Clinical Trial
Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids
Rohit Kohli et al. J Clin Endocrinol Metab. 2013 Apr.
Abstract
Context: It has been hypothesized that increased plasma bile acids (BAs) contribute to metabolic improvements after Roux-en-Y gastric bypass (RYGB) surgery by the G protein-coupled receptor TGR5-mediated effects on glucagon-like peptide-1 secretion and thyroid hormones.
Objective: The objective of this study was to evaluate the importance of bariatric surgery-induced alterations in BA physiology on factors that regulate glucose homeostasis (insulin secretion and sensitivity) and energy metabolism (resting energy expenditure and thyroid hormone axis). DESIGN, PARTICIPANTS, INTERVENTION, AND MAIN OUTCOME MEASURE: Eighteen extremely obese subjects were studied before and after 20% weight loss, induced by either laparoscopic adjustable gastric banding (LAGB) (n = 10) or RYGB surgery (n = 8).
Results: Plasma BAs more than doubled after RYGB [fasting: 1.08 (0.26-1.42) to 2.28 (1.59-3.28) μmol/L, P = .03; postprandial: 2.46 ± 1.59 to 6.00 ± 2.75 μmol/L, P = .01] but were either lower or did not change after LAGB [fasting: 1.80 (1.49-2.19) to 0.92 (0.73-1.15) μmol/L, P = .02; postprandial: 3.71 ± 2.61 to 2.82 ± 1.75 μmol/L, P = .14]. Skeletal muscle expression of TGR5 targets, Kir6.2 and cyclooxygenase IV, increased after RYGB but not LAGB. Surgery-induced changes in BAs were associated with increased peak postprandial plasma glucagon-like peptide-1 (r(2) = 0.509, P = .001) and decreased serum TSH (r(2) = 0.562, P < .001) but did not correlate with the change in insulin response to a meal (r(2) = 0.013, P = .658), insulin sensitivity (assessed as insulin stimulated glucose disposal during a hyperinsulinemic-euglycemic clamp procedure) (r(2) = 0.001, P = .995), or resting energy expenditure (r(2) = 0.004, P = .807).
Conclusions: Compared with LAGB, RYGB increases circulating BAs and TGR5 signaling, but this increase in BAs is not a significant predictor of changes in glucose homeostasis or energy metabolism.
Trial registration: ClinicalTrials.gov NCT00981500.
Figures
Figure 1.
Total and conjugated bile acid concentrations during fasting (A) and postprandial (B) conditions before and after 20% weight loss induced by RYGB surgery or LAGB. *, Significantly different from Before Surgery value, P < .03; †, significantly different from LAGB, P < .05. Values are means ± SEM.
Figure 2.
Relationship between RYGB (closed circles) and LAGB (open circles)-induced changes in postprandial total BA concentrations and the change in plasma GLP-1 (A) and TSH (B). Plasma TSH concentration (C) and skeletal muscle gene expression of Kir6.2 and COX IV (D) before and after surgery-induced 20% weight loss. *, Significantly different from Before Surgery value, P < .05. Values are means ± SEM.
References
- Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol. 2011;8:429–437 - PubMed
- Pories WJ, Dohm GL. Full and durable remission of type 2 diabetes? Through surgery? Surg Obes Relat Dis. 2009;5:285–288 - PubMed
- Goldfine AB, Shoelson SE, Aguirre V. Expansion and contraction: treating diabetes with bariatric surgery. Nat Med. 2009;15:616–617 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DK 37948/DK/NIDDK NIH HHS/United States
- P30 DK056341/DK/NIDDK NIH HHS/United States
- UL1 RR024992/RR/NCRR NIH HHS/United States
- U01 DK08505/DK/NIDDK NIH HHS/United States
- DK084310/DK/NIDDK NIH HHS/United States
- K08 DK084310/DK/NIDDK NIH HHS/United States
- UL1 TR000448/TR/NCATS NIH HHS/United States
- P30 DK020579/DK/NIDDK NIH HHS/United States
- R01 DK037948/DK/NIDDK NIH HHS/United States
- DK 56341/DK/NIDDK NIH HHS/United States
- T32 HL007456/HL/NHLBI NIH HHS/United States
- R01 DK060022/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials